Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

Published Date: 15 Sep 2023

Moderna, Inc., Cambridge. plus Immatics N. V. , a biopharmaceutical company in the clinical stages that is engaged in the discovery and creation of T cell-redirecting.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

2.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

3.

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

4.

Cancer screening rates down among American adults

5.

Some triple negative breast cancers might be avoided by longer breastfeeding


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot